tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2022 Feb 21;10(2):337.
doi: 10.3390/vaccines10020337.
Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
Foteini Malli[SUP] 1 2 [/SUP], Ioannis C Lampropoulos[SUP] 2 [/SUP], Dimitrios Papagiannis[SUP] 3 [/SUP], Ioanna V Papathanasiou[SUP] 4 [/SUP], Zoe Daniil[SUP] 2 [/SUP], Konstantinos I Gourgoulianis[SUP] 2 [/SUP]
Affiliations
Abstract
The available coronavirus disease 2019 (COVID-19) vaccines have shown their effectiveness in clinical trials. We aimed to assess the real-world effects of SARS-CoV-2 vaccinations in Greece. We combined national data on vaccinations, SARS-CoV-2 cases, COVID-19-related ICU admissions and COVID-19-related deaths. We observed 3,367,673 vaccinations (30.68% of the Greek population), 278,821 SARS-CoV-2 infections and 7401 COVID-19-related deaths. The vaccination rate significantly increased from week 2 to week 6 by 85.70%, and from week 7 to 25 by 15.65%. The weekly mean of SARS-CoV-2 cases, COVID-19 ICU patients and COVID-19 deaths markedly declined as vaccination coverage accumulated. The rate of SARS-CoV-2 cases increased significantly from week 2 to week 13 by 16.15%, while from weeks 14-25 the rate decreased significantly by 13.50%. The rate of COVID-19-related ICU admissions decreased significantly by 7.41% from week 2 to week 4, increased significantly by 17.22% from weeks 5-11, then decreased significantly from weeks 17-20, by 11.99%, and from weeks 21-25, by 16.77%. The rate of COVID-19-related deaths increased significantly from week 2 to week 15 by 12.08% and decreased significantly by 16.58% from weeks 16-25. The data from this nationwide observational study underline the beneficial impact of the national vaccination campaign in Greece, which may offer control of the SARS-CoV-2 pandemic.
Keywords: COVID-19; SARS-CoV-2; vaccination.
. 2022 Feb 21;10(2):337.
doi: 10.3390/vaccines10020337.
Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
Foteini Malli[SUP] 1 2 [/SUP], Ioannis C Lampropoulos[SUP] 2 [/SUP], Dimitrios Papagiannis[SUP] 3 [/SUP], Ioanna V Papathanasiou[SUP] 4 [/SUP], Zoe Daniil[SUP] 2 [/SUP], Konstantinos I Gourgoulianis[SUP] 2 [/SUP]
Affiliations
- PMID: 35214795
- DOI: 10.3390/vaccines10020337
Abstract
The available coronavirus disease 2019 (COVID-19) vaccines have shown their effectiveness in clinical trials. We aimed to assess the real-world effects of SARS-CoV-2 vaccinations in Greece. We combined national data on vaccinations, SARS-CoV-2 cases, COVID-19-related ICU admissions and COVID-19-related deaths. We observed 3,367,673 vaccinations (30.68% of the Greek population), 278,821 SARS-CoV-2 infections and 7401 COVID-19-related deaths. The vaccination rate significantly increased from week 2 to week 6 by 85.70%, and from week 7 to 25 by 15.65%. The weekly mean of SARS-CoV-2 cases, COVID-19 ICU patients and COVID-19 deaths markedly declined as vaccination coverage accumulated. The rate of SARS-CoV-2 cases increased significantly from week 2 to week 13 by 16.15%, while from weeks 14-25 the rate decreased significantly by 13.50%. The rate of COVID-19-related ICU admissions decreased significantly by 7.41% from week 2 to week 4, increased significantly by 17.22% from weeks 5-11, then decreased significantly from weeks 17-20, by 11.99%, and from weeks 21-25, by 16.77%. The rate of COVID-19-related deaths increased significantly from week 2 to week 15 by 12.08% and decreased significantly by 16.58% from weeks 16-25. The data from this nationwide observational study underline the beneficial impact of the national vaccination campaign in Greece, which may offer control of the SARS-CoV-2 pandemic.
Keywords: COVID-19; SARS-CoV-2; vaccination.